Navigation Links
Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer
Date:1/10/2012

CHICAGO (January 10, 2012) According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment. As a result, the study's investigators determined that there is a need for improvements in the quality of the surgical decision-making process for these patients.

The retrospective study sought to evaluate the quality of the decision-making process regarding the options for surgical treatment. The "quality" for early-stage breast cancer patients in this study was defined as the degree to which a decision was informed and consistent with patient preferences. Although several other studies have found knowledge gaps and identified specific patient concerns that affect decisions about breast cancer surgery,i ii iii this is the first study that attempted to examine how often treatments actually reflect patient preferences.

Surveys were mailed to adult women with a history of early-stage invasive breast cancer (stages I and II) treated at one of four academic medical centers: The Dana-Farber Cancer Institute, Boston; Massachusetts General Hospital, Boston; University of California, San Francisco; and University of North Carolina, Chapel Hill. Patients answered about half of the questions right (average knowledge score was 52.7 percent), indicating some large gaps in knowledge for information that providers identified as critical. Less than half (48.6 percent) of study participants reported that their surgeon asked them about their preference regarding surgical treatment.

The data was collected an average of two-and-a-half years following the surgical procedure and recognized the fact that patients are likely to forget some information over time. However, the knowledge gaps concern
'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
2. More surgery in early-stage laryngeal cancer treatment; more chemoradiation for advanced-stage
3. Hidden cancer cells not a factor in early-stage breast cancer survival rates
4. Early-stage melanoma tumors contain clues to metastatic potential
5. UBC researchers to lead $4.7-million study on early-stage oral cancer
6. Protein test detects early-stage, asbestos-related pulmonary cancer
7. New test detects early-stage, asbestos-related pulmonary cancer
8. Voice-saver: Light therapy for early-stage laryngeal cancer
9. Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear
10. Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer
11. Proton therapy safe, effective for early-stage lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Chinese researchers say a protein that makes ... be used as a prognostic indicator in people on chemotherapy ... full article on the study , just posted on the ... Respiratory Medicine at Shandong University Hospital in China analyzed the ... between 1995 and 2013. They found that, the lower the ...
(Date:7/30/2014)... 2014 The Independent Woman , ... holding 5 free financial workshops in the San Francisco ... goal of these workshops is our collective success, linking ... financial empowerment. , These workshops were designed by women, ... successful investor, entrepreneur, and bestselling author (Rich Woman and ...
(Date:7/30/2014)... 2014 It is often said the reason that ... be in life is because they only use about ten per ... this belief is only an erroneous myth propagated as ... they been only “smarter”. , So, success in life is defined ... to work hard for that success. Thankfully, some people have finally ...
(Date:7/30/2014)... July 30, 2014 With the ... of personal health expenditure as well as the ... system, China diagnostic reagent industry has been developing ... 90%. In 2013, Chinese in vitro diagnostics market ... came from in vitro diagnostic reagents. , ...
(Date:7/30/2014)... 30, 2014 Computer Resources of America, ... in New York City, has been awarded the contract ... headquarters of a large global bank. The bank is ... Chico Ramnarayan, CEO of CRA said, “Being awarded this ... to further develop what has already been a successful ...
Breaking Medicine News(10 mins):Health News:Study Finds Common Blood Protein May Predict Mesothelioma Survival, Reports Surviving Mesothelioma 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 3Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4
... January 14, 2009 Obesity continues to increase for ... Mexican-American women. Between the ages of 35-44, there are ... and 575,000 Mexican-American women who are obese. A new ... reveals that there is an increased risk for ...
... LIVONIA, Mich., Jan. 14 On the heels of ... 11 states, American Community,Mutual Insurance Company today announced that ... Indiana. Designed to help consumer,s hold,down their medical expenses, ... through independent agents for a coverage effective date beginning,March ...
... much about it. FlameEz.com is launched to provide the latest information ... of the most feared illnesses in middle and old age. ... ... Millions of Americans are affected by chronic inflammation without knowing much ...
... SHANGHAI, China, Jan. 14 /PRNewswire-Asia-FirstCall/ -- China-Biotics, ... Company"), a leading Chinese firm,specializing in the ... products, today announced it has signed contracts,with ... Co., Ltd. ("Yuejia Food"),Shandong Huwa Dairy Industry ...
... N.Y., Jan. 14 /PRNewswire/ -- Scarguard Labs, ... of scars and other dermatological problems through the use ... system, announced it has appointed Richard E. Pino as ... Company,s finance, accounting, and treasury functions and will report ...
... in outbreak rises to 425 in 43 states, CDC says ... of people sickened by salmonella-contaminated peanut butter rose to 425 ... death in Minnesota and two in Virginia were probably tied ... the three people, whose names and hometowns haven,t been released, ...
Cached Medicine News:Health News:Economic status affects obesity rates in Mexican-American and white women 2Health News:American Community Introduces Community Flex(TM), an Affordable Health Plan in Arizona and Indiana 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 2Health News:Control of Inflammation May Benefit Many of the Most Feared Illnesses in Middle and Old Age 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 4Health News:Scarguard Labs, LLC Appoints Richard E. Pino as CFO 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 2Health News:Salmonella Linked to Deaths in Virginia, Minnesota 3
(Date:7/30/2014)... 30, 2014 Silicon Valley Bank, the bank ... today that examines the merger, acquisition and IPO ... According to the annual report based on 2013 data, ... since SVB started tracking the data in 2005. ... on solid healthcare M&A activity over the last few ...
(Date:7/30/2014)... and SAN DIEGO , July 30, ... ARNA ) announced today that an article based on ... lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and ... recently published in the online issue of Obesity , ... objective of these analyses was to identify whether there is ...
(Date:7/30/2014)... and NEW YORK , ... ACCP), a developer of new products for oncology supportive ... MuGard ® , has been featured in an article ... Mucositis Symptoms in Head and Neck Cancers."  Dr. ... provides insight on the growing demand seen in the ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... smartest choice , ... event is to ... environment. But will the device be durable enough? Can ... on its signal quality? Will the battery last? Is it comfortable, ...
... ideal as a primary chemistry-immuno analyzer ... laboratories or as a dedicated specialty ... consolidate chemistry-immuno testing with Olympus 122 ... specific proteins, esoteric chemistries and tests ...
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... nm and 940 nm) laser system is ... solid-state laser quickly and effectively treats vascular ... offers the clinical versatility to precisely target ... vessels in a convenient, affordable package. , ...
Medicine Products: